Evidence map›Paper›PMID 28668150›Full record

SynthesisFertility and sterility2017

Reevaluating response and failure of medical treatment of endometriosis: a systematic review.

Christian M Becker, William T Gattrell, Kerstin Gude, Sukhbir S Singh

3 registry-linked trialsOpen access · hybridAbstract readMeta-AnalysisSystematic Review
In one paragraph

Synthesis in Fertility and sterility, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 3 registered trials, which are not on this map. Cited by 130 papers, 10 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
130citing papers in PubMed, 10 pooled it
18.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05643131 nanot yet recruitingnot on this mapstarted 2025, after this paper: background citation

Evaluation of the Hyivy Device as a Non-hormonal Therapy in People With Endometriosis

TypeinterventionalSponsorHyivy Health IncRan2025 to 2026Enrolled20ConditionsEndometriosis, Pelvic PainArmsHyivy Intravaginal Device
NCT06510647 unknown statusnot on this mapstarted 2024, after this paper: background citation

Risk Factors for Hormonal Therapy Failure in Patients With Endometriosis.

Typeobservational_patient_registrySponsorUniversity of CagliariRan2024 to 2026Enrolled247ConditionsEndometriosisArmsHormonal Therapy Agent
NCT06611501 phase2active not recruitingnot on this mapstarted 2025, after this paper: background citation

Glycemic Regulation as Endometriosis Adjunct Treatment

TypeinterventionalSponsorBoston Children's HospitalRan2025 to 2027Enrolled14ConditionsPelvic Pain, EndometriosisArmsMetformin Hydrochloride, Placebo
3 · Its place in the literature

Who cites it

130 citing papers in PubMed, 10 syntheses or guidelines pooled it, 283 citations in OpenAlex.

  1. Guideline
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Selective oestrogen receptor modulators (SERMs) for endometriosis.The Cochrane database of systematic reviews · 2021
    Pooled it
  9. Pooled it
  10. Pooled it
  11. Trial
  12. Trial
  13. Trial
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

70 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 4 institutions in 3 countries.

Christian M BeckerEndometriosis Care Centre, Nuffield Department of Obstetrics and Gynaecology, University of Oxford, Oxford, United Kingdom. Electronic address: christian.becker@obs-gyn.ox.ac.uk.
William T GattrellResearch Evaluation Unit, Oxford Pharmagenesis, Oxford, United Kingdom; Department of Mechanical Engineering and Mathematical Sciences, Oxford Brookes University, Oxford, United Kingdom.
Kerstin GudeMedical Affairs Women's Healthcare, Bayer, Berlin, Germany.
Sukhbir S SinghDepartment of Obstetrics and Gynaecology, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.
Bayer (Germany) · DEEndometriosis · GBOttawa Hospital Research InstituteOxford Brookes University · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo assess patient response rates to medical therapies used to treat endometriosis-associated pain.

designA systematic review with the use of Medline and Embase.

settingNot applicable. PATIENT(S): Women receiving medical therapy to treat endometriosis. INTERVENTIONS(S): None. MAIN OUTCOME MEASURE(S): The proportions of patients who: experienced no reduction in endometriosis-associated pain symptoms; had pain symptoms remaining at the end of the treatment period; had pain recurrence after treatment cessation; experienced an increase or no change in disease score during the study; were satisfied with treatment; and discontinued therapy owing to adverse events or lack of efficacy. The change in pain symptom severity experienced during and after treatment, as measured on the visual analog scale, was also assessed. RESULT(S): In total, 58 articles describing 125 treatment arms met the inclusion criteria. Data for the response of endometriosis-associated pain symptoms to treatment were presented in only 29 articles. The median proportions of women with no reduction in pain were 11%-19%; at the end of treatment, 5%-59% had pain remaining; and after follow-up, 17%-34% had experienced recurrence of pain symptoms after treatment cessation. After median study durations of 2-24 months, the median discontinuation rates due to adverse events or lack of efficacy were 5%-16%. CONCLUSION(S): Few studies of medical therapies for endometriosis report outcomes that are relevant to patients, and many women gain only limited or intermittent benefit from treatment.

Indexed as

CausalityComorbidityEndometriosisFemaleHumansPain MeasurementPelvic PainPrevalenceTreatment OutcomeEndometriosismedical therapypainsystematic review

Identifiers

PMID28668150
PMCPMC5494290
OpenAlexW2725337807

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.